Neuroglee Therapeutics

Neuroglee Therapeutics is a pioneering healthcare startup based in Singapore, specializing in the field of digital therapeutics. The company focuses on creating virtual, AI-driven therapy solutions for neurodegenerative diseases, primarily working towards revolutionizing the way we treat brain health disorders. Their main target is to develop a patient-centric approach in managing diseases like Alzheimer's and other forms of dementia.

Founded by Aniket Singh Rajput, the startup is backed by a team of professionals with diverse expertise in neurology, technology, and artificial intelligence. They strive to bridge the gap in neurodegenerative disease management by creating personalized, virtual therapeutic solutions that are rooted in advanced technology. Their work combines therapeutic content, prioritized care pathways, and predictive analytics to optimize patient outcomes.

Neuroglee's flagship product, NG-001, is an AI-driven software designed to provide early intervention for Alzheimer's patients. Utilizing machine learning algorithms, the software delivers personalized therapies based on the patient's disease progression, their response to treatment, and their cognitive, physical, and emotional needs. Neuroglee aspires to make their technology an integral part of managing and treating neurodegenerative diseases worldwide, significantly improving the quality of life for these patients.

Company Details